Qualcomm’s subsidiary Qualcomm Life will partner with Boehringer Ingelheim to develop a connectivity solution for Boehringer’s platform inhaler, the RESPIMAT inhaler with a view to improve chronic obstructive pulmonary disease (COPD) treatment results.

RESPIMAT is an inhalation spray which is administered through two puffs once each day to control symptoms induced by COPD in adults.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

Based on the 2net Design platform, Qualcomm Life will develop the prototype of a small, wireless, low-power, disposable module for the RESPIMAT inhaler.

"Qualcomm Life is committed to powering the Internet of Medical Things to ultimately enable intelligent care to be delivered wherever the patient may be."

2net Design is a platform to design the communications components of connected medical devices as well as disposable drug delivery devices and disposable diagnostic devices for condition specific connected therapies.

The fully integrated inhaler can seamlessly connect with Qualcomm Life’s 2net Platform which will enable the tracking of puffs from the RESPIMAT inhaler.

See Also:

The information can then be relayed to health care providers and the patients who have been prescribed with the RESPIMAT medicines.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Qualcomm Life president Rick Valencia said: “Qualcomm Life is committed to powering the Internet of Medical Things to ultimately enable intelligent care to be delivered wherever the patient may be.

“We are excited to be collaborating with an industry leader like Boehringer Ingelheim to deliver a more seamless digital health experience that can enable their COPD patients to better manage their disease.”

The collaboration is expected to combine Boehringer experience in COPD medicines with Qualcomm Life’s expertise in developing reference designs for wireless, single-use and small integrated modules to support administration of daily treatment regimens.